SleepUp Tecnologia em Saúde LTDA
São Caetano do Sul, São Paulo, 09530-250, Brazil
Location status: Recruiting
NCT Number: NCT04949360
Cognitive-Behavioral Therapy for insomnia (CBTi) is a well-established therapeutic intervention for insomnia. SleepUp provides a digital therapeutics platform based on CBTi and additional features. This clinical trial aims at analyzing the efficacy of the CBTi-based platform offered by SleepUp in reducing symptoms of insomnia and will be conducted in 2 phases.
Phase 1
The sample will be composed of 160 individuals, both males and females, from 20 to 60 years old, with insomnia symptoms considered as at least mild. Those who accept to participate will be randomized and distributed in four groups:
* Standard CBTi (CBTi-S): This treatment consists of an eight-week treatment composed by weekly and structure appointments with board-certified sleep psychologists. The appointments will be made remotely (video calls with psychologists). * Minimal intervention - Sleep hygiene (MI-SH): This group will receive an educational program on sleep hygiene through the SleepUp app. Its content covers topics that are also covered in the online CBTi sessions. This procedure is more adequate as a control than the commonly used no treatment or waiting list controls, due to the behavioral * Online CBTI (CBTI-O): This group will receive access to an eight-weeks CBTi-based treatment through the SleepUp app. The participants of this group will receive interventions equivalent to the standard in-person CBTi, but provided through a digital platform. * Online CBTi + additional features (CBTi-O+): This group will have access to the complete premium version of SleepUp platform. It includes those presented in the CBTi-O group and other therapeutic and complementary features (including meditation audios and videos, mindfulness therapy, relaxation soundtracks, sleep hygiene tips, virtual assistant, and telehealth.
All participants in all groups will be assessed periodically throughout the eight weeks of intervention with standard sleep questionnaires and sleep logs. Equivalent intervals will be applied to the MI-SH group.
Phase 2
This phase will comprise 120 individuals, both males and females, from 20 to 60 years old, with insomnia symptoms considered as at least mild. Those who accept to participate will be randomized and distributed in three groups:
* Minimal intervention - Sleep hygiene (MI-SH): This group will receive an educational program on sleep hygiene through the SleepUp app. Its content covers topics that are also covered in the online CBTi sessions. This procedure is more adequate as a control than the commonly used no treatment or waiting list controls, due to the behavioral * Online CBTI (CBTI-O): This group will receive access to an eight-weeks CBTi-based treatment through the SleepUp app. The participants of this group will receive interventions equivalent to the standard in-person CBTi, but provided through a digital platform. * Online CBTi + additional features (CBTi-O+): This group will have access to the complete premium version of SleepUp platform. It includes those presented in the CBTi-O group and other therapeutic and complementary features (including meditation audios and videos, mindfulness therapy, relaxation soundtracks, sleep hygiene tips, virtual assistant, and telehealth.
All participants in all groups will be assessed periodically throughout the eight weeks of intervention with standard sleep questionnaires and sleep logs. Equivalent intervals will be applied to the MI-SH group.
Interested in participating?
Request Info20 year–60 year
All sexes
Interventional
Not applicable
São Caetano do Sul, São Paulo, 09530-250, Brazil
Location status: Recruiting
Cognitive-Behavioral Therapy for insomnia (CBTi) is a well-established therapeutic intervention for insomnia. In its standard presentation, it is composed by 6 to 12 weekly appointments with a board-certified sleep psychologist. SleepUp provides a digital therapeutics platform based on CBTi and additional features. This clinical trial aims at analyzing the efficacy of the CBTi-based platform offered by SleepUp in reducing symptoms of insomnia.
The participants will be recruited based on advertising on social media and invited to participate. Those participants who are eligible in accordance to the inclusion and exclusion criteria will be contact by a member of the research team who will provide a consent form and will explain the terms and conditions of this research project. The sample will be composed of 160 individuals in Phase 1 and by 120 individuals in Phase 2, both males and females, from 20 to 60 years old, with insomnia symptoms considered as at least mild, according to the Insomnia Severity Index (ISI). All groups shall have similar proportions of gender and of insomnia symptoms severity.
Phase 1
Those who accepted to participate will be randomized and distributed in four groups:
Phase 2
Those who accepted to participate will be randomized and distributed in three groups:
All participants in all groups will be assessed periodically throughout the eight weeks of intervention. Equivalent intervals will be applied to the SH-MI group. The following clinical questionnaires and scales will be used:
Healthy volunteers accepted: No
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
The CBTi-O and CBTi-O+ interventions are based on real life user experience. The users will have access to different versions of the platform. The intervention will last eitght weeks.
This is the gold standard behavioral treatment for insomnia and will be performed by independent board-certified sleep psychologists. The treatments will last eight weeks and the appointments will be made by video-calls.
It is composed by educational material about normal sleep pattern and sleep hygiene. It will be delivered by SleepUp app.
Time frame: From enrollment (baseline) to the end of treatment at 8 weeks
It will be measured as the percentage of participants who completed the treatment, out of those who effectively initiated it. Dropouts will be considered whenever a participants fail to comply with the tasks relative to each group for two consecutive weeks, or postpone the completion of these tasks for three times. These tasks refer to the responses to periodic questionnaires and to the completion of the CBTi or CBTi-O sessions (when applicable).The aim of this comparison is to evaluate whether the adherence rate in the CBTi-O and CBTi-O+ groups are similar to the standard treatment (CBTi-S) or higher than the minimal treatment (MI-SH).
Time frame: From enrollment (baseline) to the end of treatment at 8 weeks
Patients are considered to be responsive to treatment if the ISI score is at least 7 points lower than on the basal evaluation.
Time frame: From enrollment (baseline) to the end of treatment at 8 weeks
Patients are considered to be with no symptoms of insomnia if the ISI score is lower then 8.
Time frame: From enrollment (baseline) to the end of treatment at 8 weeks
Sleep efficiency will be measured by sleep logs
Time frame: From enrollment (baseline) to the end of treatment at 8 weeks
Sleep hygiene habits will be measured by the Sleep Hygiene Index
Time frame: From enrollment (baseline) to the end of treatment at 8 weeks
Excessive daytime sleepiness will be measured using the Epworth Sleepiness Scale
Time frame: From enrollment (baseline) to the end of treatment at 8 weeks
Sleep quality will be measured by the Pittsburgh Sleep Quality Index
Time frame: From enrollment (baseline) to the end of treatment at 8 weeks
Sleep latency will be measured by sleep logs
Time frame: From enrollment (baseline) to the end of treatment at 8 weeks
Sleep duration will be measured by sleep logs
Contact information is provided by the study sponsor or research team.
Gabriel N. Pires, PhD
CONTACT
Pesquisa SleepUp
CONTACT
SleepUp Tecnologia em Saúde Ltda
Industry
Evaluation of SleepUp Digital CBTi-based Platform in the Treatment of Insomnia
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT06155916
Dyssomnias, Insomnia
Helsinki, HUS, Finland
View Trial DetailsNCT06737055
Behavior, Depression, Postpartum
Providence, Rhode Island, United States
View Trial DetailsNCT06222255
Colonic Diseases, Colorectal Neoplasms
Seoul, Jongro-gu, South Korea
View Trial DetailsNCT05321355
Apnea, Disorders of Excessive Somnolence
Mainz, Rhineland-Palatinate, Germany
View Trial Details